3/7/12 20:41  | 3/6/12  | MITI | Health | BioPrd | Biological Products, (No Diag | Amgen Inc | CA | T |  | P.m | 322,340 | 11.00 | 21 | 29,304 | 41 | 100,635 | M | 39 | 105 | 151 | 69 | 34 | 0 | 0 | 0 |  |  |  |  |  |  | 
3/6/12 19:53  | 3/2/12  | MITI | Health | BioPrd | Biological Products, (No Diag | Amgen Inc | CA | T |  | P.m | 27,372 | 11.00 | 25 | 2,488 | 3 | 82,513 | I | 40 | 94 | 136 | 73 | 34 | 0 | 0 | 0 | 0 |  |  |  |  |  | 
3/18/11 17:57  | 3/16/11  | MITI | Health | BioPrd | Biological Products, (No Diag | Johann Peter | 2M | D |  | P | 25 | 5.08 | 4 | 5 | 0 | 3,270 | D | 96 | -33 | -24 | -33 | -19 | -11 | -10 | -4 | 4 | 4 | 22 | 11 | 0 |  | 
10/3/08 20:53  | 10/2/08  | MITI | Health | BioPrd | Biological Products, (No Diag | Johann Peter | 2M | D |  | P.d | 545 | 4.21 | 1 | 129 | 10 | 1,380 | M | 58 | 117 | 108 | 58 | -39 | -31 | -11 | 1 | -2 | -8 | -5 | 1 | -28 | 42 | 
10/3/08 20:51  | 10/2/08  | MITI | Health | BioPrd | Biological Products, (No Diag | Berriman John E | 2M | D |  | P.d | 50 | 4.21 | 1 | 12 | New | 12 | D | 58 | 117 | 108 | 58 | -39 | -31 | -11 | 1 | -2 | -8 | -5 | 1 | -28 | 42 | 
10/3/08 20:49  | 10/2/08  | MITI | Health | BioPrd | Biological Products, (No Diag | Slattery Joseph P | MD | D |  | P.d | 25 | 4.21 | 1 | 6 | New | 6 | D | 58 | 117 | 108 | 58 | -39 | -31 | -11 | 1 | -2 | -8 | -5 | 1 | -28 | 42 | 
8/22/07 18:40  | 8/20/07  | MITI | Health | BioPrd | Biological Products, (No Diag | Johann Peter | 2M | D |  | P | 10 | 1.92 | 0 | 5 | 0 | 3,135 | D |  | -26 | -33 | -20 | -30 | -15 | -13 | -4 | 2 | 3 | 6 | -18 | -24 | 223 | 
6/26/07 18:51  | 6/22/07  | MITI | Health | BioPrd | Biological Products, (No Diag | Benjamin Jerry | X0 | D |  | P.d | 977 | 2.69 | 0 | 363 |  | 76 | I |  | -48 | -20 | -14 | -11 | -11 | -6 | -7 | -6 | 0 | 1 | -14 | -18 | 13 | 
6/26/07 18:37  | 6/22/07  | MITI | Health | BioPrd | Biological Products, (No Diag | Omega Fund Management Ltd | X0 | T |  | P.d | 4,398 | 2.69 | 0 | 1,635 | 50 | 4,893 | I |  | -48 | -20 | -14 | -11 | -11 | -6 | -7 | -6 | 0 | 1 | -14 | -18 | 13 | 
6/26/07 17:51  | 6/22/07  | MITI | Health | BioPrd | Biological Products, (No Diag | Johann Peter | 2M | D |  | P.d | 2,443 | 2.69 | 0 | 908 | 224 | 1,314 | I |  | -48 | -20 | -14 | -11 | -11 | -6 | -7 | -6 | 0 | 1 | -14 | -18 | 13 | 
6/26/07 17:12  | 6/22/07  | MITI | Health | BioPrd | Biological Products, (No Diag | Hale David F | MD | D |  | P.d | 49 | 2.69 | 0 | 18 | 8 | 235 | I |  | -48 | -20 | -14 | -11 | -11 | -6 | -7 | -6 | 0 | 1 | -14 | -18 | 13 | 
7/26/06 19:25  | 7/24/06  | MITI | Health | BioPrd | Biological Products, (No Diag | Johann Peter | 2M | D |  | P.d | 8,000 | 3.60 | 0 | 2,222 | New | 2,222 | I |  |  |  |  | -25 | -22 | -16 | -17 | 15 | -3 | -15 | -16 | -16 | -21 | 
11/6/03 18:12  | 11/4/03  | CNVX | Health | BioPrd | Biological Products, (No Diag | Van Epps Dennis E | CA | O | VP,Resea | P | 3 | 12.00 | 0 | 0 | 1 | 34 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/6/03 18:08  | 11/4/03  | CNVX | Health | BioPrd | Biological Products, (No Diag | Schoettler Gail | CA | D |  | P | 60 | 12.00 | 0 | 5 | 81 | 11 | M |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/6/03 18:07  | 11/4/03  | CNVX | Health | BioPrd | Biological Products, (No Diag | Royston Ivor | CA | D |  | P | 102 | 12.00 | 0 | 9 |  | 8 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/6/03 18:01  | 11/4/03  | CNVX | Health | BioPrd | Biological Products, (No Diag | Phillips Barclay A | CA | D |  | P | 6 | 12.00 | 0 | 1 | 8 | 7 | M |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/6/03 17:21  | 11/4/03  | CNVX | Health | BioPrd | Biological Products, (No Diag | Laforce James | CA | D |  | P | 30 | 12.00 | 0 | 3 | 7 | 40 | M |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/6/03 17:10  | 11/4/03  | CNVX | Health | BioPrd | Biological Products, (No Diag | Gammon Guy | CA | O | VP,Clini | P | 4 | 12.00 | 0 | 0 | 1 | 23 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/6/03 16:44  | 11/4/03  | CNVX | Health | BioPrd | Biological Products, (No Diag | Aker Hazel M | CA | O | SVP,GC | P | 4 | 12.00 | 0 | 0 | 1 | 40 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  |